Report cover image

Global Eyedrops Market Growth 2025-2031

Published Aug 07, 2025
Length 107 Pages
SKU # LPI20288944

Description

The global Eyedrops market size is predicted to grow from US$ 16840 million in 2025 to US$ 23360 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Eye drops are liquid preparations that act directly on the eyes, mainly used to treat, relieve or prevent various eye diseases and discomfort symptoms. By dripping into the conjunctival sac, the drug ingredients can quickly act on the surface of the eyeball or the tissue inside the eye. It has the characteristics of rapid onset, high local concentration and small systemic side effects. According to the purpose, it can be divided into fatigue relief type, antibacterial and anti-inflammatory type, artificial tear type, anti-allergic type, intraocular pressure lowering type, etc. In sales statistics, "piece" is the basic unit, which refers to the smallest retail package, and one piece contains a single bottle or multiple eye drops.

The global eye drops market is driven by three main factors: the aging population and the popularity of electronic products have led to a high incidence of eye diseases such as dry eye; innovative drug research and development has promoted the expansion of treatment areas; and consumption upgrades in emerging markets. The development of eye drops faces three major restrictions: stricter regulatory policies in various countries, especially restrictions on products containing preservatives; foreign giants monopolize the high-end market; and competition in the mid- and low-end markets is highly homogenized. The Chinese market is growing the fastest, but local companies need to break through technical and brand barriers to compete with foreign capital.

LP Information, Inc. (LPI) ' newest research report, the “Eyedrops Industry Forecast” looks at past sales and reviews total world Eyedrops sales in 2024, providing a comprehensive analysis by region and market sector of projected Eyedrops sales for 2025 through 2031. With Eyedrops sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eyedrops industry.

This Insight Report provides a comprehensive analysis of the global Eyedrops landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eyedrops portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eyedrops market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eyedrops and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eyedrops.

This report presents a comprehensive overview, market shares, and growth opportunities of Eyedrops market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Fatigue Relief Type
Antibacterial and Anti-inflammatory Type
Artificial Tears Type
Anti-allergic Type
IOP Lowering Type
Others

Segmentation by Application:
Pharmacies
Hospitals and Clinics
Online Sales
Optics Stores

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AbbVie
Alcon
Bausch and Lomb
Santen
Zhenshiming
Yuanda Pharmaceutical
Freda Pharmaceutical
Renhe Group
Shapuaisi
Kanghong Pharmaceutical
Essen Biopharma
Zhongsheng Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Eyedrops market?

What factors are driving Eyedrops market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Eyedrops market opportunities vary by end market size?

How does Eyedrops break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

107 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Eyedrops by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Eyedrops by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.